Temozolomide preferentially depletes cancer stem cells in glioblastoma.
Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP.
Beier D, et al. Among authors: beier cp.
Cancer Res. 2008 Jul 15;68(14):5706-15. doi: 10.1158/0008-5472.CAN-07-6878.
Cancer Res. 2008.
PMID: 18632623